NCT02514499View on ClinicalTrials.gov

Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study

NACompletedINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
BRCA1/2 Negative
Interventions
OTHER

Questionnaires

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02514499 - Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study | Biotech Hunter | Biotech Hunter